Exopolysaccharide synthesized by Lactobacillus reuteri decreases the ability of enterotoxigenic Escherichia coli to bind to porcine erythrocytes

Appl Environ Microbiol. 2010 Jul;76(14):4863-6. doi: 10.1128/AEM.03137-09. Epub 2010 May 14.

Abstract

This study investigated the therapeutic potential of bacterial polysaccharides by employing a model system based on enteroxigenic Escherichia coli (ETEC)-induced hemagglutination of erythrocytes. Exopolysaccharides produced by strains of Lactobacillus reuteri inhibited ETEC-induced hemagglutination of porcine erythrocytes. No effect was observed for dextran produced from Weissella cibaria and commercially available oligo- and polysaccharides.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / isolation & purification
  • Anti-Bacterial Agents / metabolism*
  • Anti-Bacterial Agents / pharmacology
  • Antibiosis*
  • Bacterial Adhesion*
  • Enterotoxigenic Escherichia coli / drug effects*
  • Enterotoxigenic Escherichia coli / pathogenicity
  • Erythrocytes / microbiology*
  • Hemagglutination / drug effects
  • Leuconostocaceae / metabolism
  • Limosilactobacillus reuteri / metabolism*
  • Polysaccharides, Bacterial / isolation & purification
  • Polysaccharides, Bacterial / metabolism*
  • Polysaccharides, Bacterial / pharmacology
  • Swine

Substances

  • Anti-Bacterial Agents
  • Polysaccharides, Bacterial